中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 2
Feb.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(2): 327-334

Effect of kinesin family member 15 on the proliferation of hepatocellular carcinoma cells and its mechanism of action

DOI: 10.12449/JCH240217
  • 1.

    Department of Hepatobiliary Surgery，Affiliated Drum Tower Hospital of Nanjing University Medical School，Nanjing 210008，China

  • 2.

    Department of Basic Medicine，Nanjing University Medical School，Nanjing 210093，China

Research funding:

National Natural Science Foundation of China (81972888)

More Information
  • Corresponding author: JIANG Chunping， chunpingjiang@126.com （ORCID： 0000-0001-8256-5731）
  • Received Date: 2023-05-29
  • Accepted Date: 2023-07-04
  • Published Date: 2024-02-19
    Abstract
  •   Objective  To investigate the effect of kinesin family member 15 （KIF15） on the proliferation of hepatocellular carcinoma （HCC） cells and its mechanism of action.  Methods  TCGA and GEPIA datasets were analyzed to determine the expression of KIF15 in HCC and its effect on tumor stage and survival. Quantitative real-time PCR and Western blot were used to measure the expression level of KIF15 in human-derived HCC cell lines （HepG2， Hep3B， MHCC-97H， and LM3） and human normal liver cell line L02 cultured in vitro， and Hep3B and HepG2 were selected for subsequent studies. CCK-8 assay， plate colony formation assay， and EdU staining were performed for Hep3B cells transfected with shRNA-NC or shRNA-KIF15 and HepG2 cells transfected with LV-vector or LV-KIF15 to evaluate the viability and proliferative capacity of these cells. GSEA was used to analyze the potential signaling pathways associated with KIF15 in HCC， and Western blot was used for detection. The independent-samples t test was used for comparison of continuous data between two groups； a one-way analysis of variance was used for comparison between multiple groups， and the least significant difference t-test was used for further comparison between two groups.  Results  The analysis of TCGA and GEPIA datasets showed that in HCC patients， the expression of KIF15 in HCC tissue was significantly higher than that in normal tissue， and the HCC patients with high KIF15 expression tended to have a poorer prognosis. Compared with sh-NC-Hep3B， sh3-Hep3B showed significant reductions in the mRNA and protein levels of KIF15 （P<0.05）， cell viability， clone formation number， and EdU positive rate （all P<0.05）. Compared with vector-HepG2， LV-KIF15-HepG2 showed significant increases in the mRNA and protein levels of KIF15 （P<0.05）， cell viability， clone formation number， and EdU positive rate （all P<0.05）. Subcutaneous tumor assay showed that compared with sh-NC-Hep3B， sh3-Hep3B showed reductions in tumor volume and tumor weight， as well as a significant reduction in the immunohistochemical score of Ki67 and a significant increase in the immunohistochemical score of TUNEL （P<0.05）. GSEA analysis showed that the PI3K/AKT/mTOR pathway was positively correlated with KIF15 in HCC （NES=1.59， P<0.001）. Western blot showed that LY294002 could inhibit the PI3K/AKT/mTOR pathway upregulated in LV-KIF15-HepG2， and compared with LV-KIF15-HepG2， LY294002+LV-KIF15-HepG2 showed significant reductions in cell viability， clone formation number， and EdU positive rate （all P<0.05）.  Conclusion  KIF15 enhances the viability and proliferative capacity of HCC cells by upregulating the PI3K/AKT/mTOR signaling pathway.

     

    • FullText(HTML)
  • loading
    • References(25)
  • [1]
    YU SJ. Immunotherapy for hepatocellular carcinoma: Recent advances and future targets[J]. Pharmacol Ther, 2023, 244: 108387. DOI: 10.1016/j.pharmthera.2023.108387.
    [2]
    BROWN ZJ, TSILIMIGRAS DI, RUFF SM, et al. Management of hepatocellular carcinoma: A review[J]. JAMA Surg, 2023, 158( 4): 410- 420. DOI: 10.1001/jamasurg.2022.7989.
    [3]
    ALMEIDA AC, MAIATO H. Chromokinesins[J]. Curr Biol, 2018, 28( 19): R1131- R1135. DOI: 10.1016/j.cub.2018.07.017.
    [4]
    BEGLEY MA, SOLON AL, DAVIS EM, et al. K-fiber bundles in the mitotic spindle are mechanically reinforced by Kif15[J]. Mol Biol Cell, 2021, 32( 22): br11. DOI: 10.1091/mbc.E20-06-0426.
    [5]
    LUO Y, ZHANG B, XU L, et al. Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling[J]. Histol Histopathol, 2022, 37( 3): 269- 285. DOI: 10.14670/HH-18-408.
    [6]
    GE W, CHEN Y, GUO Y, et al. KIF15 upregulation promotes leiomyosarcoma cell growth via promoting USP15-mediated DEK deubiquitylation[J]. Biochem Biophys Res Commun, 2021, 570: 117- 124. DOI: 10.1016/j.bbrc.2021.07.042.
    [7]
    TAO J, SUN G, LI Q, et al. KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis[J]. J Cell Physiol, 2020, 235( 12): 9388- 9398. DOI: 10.1002/jcp.29743.
    [8]
    RUMGAY H, ARNOLD M, FERLAY J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040[J]. J Hepatol, 2022, 77( 6): 1598- 1606. DOI: 10.1016/j.jhep.2022.08.021.
    [9]
    SUN Y, ZHANG W, BI X, et al. Systemic therapy for hepatocellular carcinoma: Chinese consensus-based interdisciplinary expert statements[J]. Liver Cancer, 2022, 11( 3): 192- 208. DOI: 10.1159/000521596.
    [10]
    SIEGEL RL, MILLER KD, FUCHS HE, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72( 1): 7- 33. DOI: 10.3322/caac.21708.
    [11]
    Chinese Association of Liver Cancer of Chinese Medical Doctor Association. Chinese expert consensus on the whole‐course management of hepatocellular carcinoma(2023 edition)[J]. Chin J Dig Surg, 2023, 22( 7): 824- 842. DOI: 10.3760/cma.j.cn115610-20230605-00261.

    中国医师协会肝癌专业委员会. 肝细胞癌全程管理中国专家共识(2023版)[J]. 中华消化外科杂志, 2023, 22( 7): 824- 842. DOI: 10.3760/cma.j.cn115610-20230605-00261.
    [12]
    ZHANG S, TU Q, QIAN X, et al. Deficiency of Kif15 gene inhibits tumor growth due to host CD8+T lymphocytes increase[J]. Biochem Biophys Res Commun, 2023, 655: 110- 117. DOI: 10.1016/j.bbrc.2023.03.006.
    [13]
    VANNESTE D, FERREIRA V, VERNOS I. Chromokinesins: localization-dependent functions and regulation during cell division[J]. Biochem Soc Trans, 2011, 39( 5): 1154- 1160. DOI: 10.1042/BST0391154.
    [14]
    HE Z, WANG J, XU J, et al. Dynamic regulation of KIF15 phosphorylation and acetylation promotes focal adhesions disassembly in pancreatic cancer[J]. Cell Death Dis, 2022, 13( 10): 896. DOI: 10.1038/s41419-022-05338-y.
    [15]
    SUN RF, HE N, ZHANG GY, et al. Combined inhibition of KIF11 and KIF15 as an effective therapeutic strategy for gastric cancer[J]. Curr Cancer Drug Targets, 2023, 23( 4): 293- 306. DOI: 10.2174/1568009622666220616122846.
    [16]
    QUAN G, XU J, WANG J, et al. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer[J]. Cell Death Dis, 2023, 14( 2): 137. DOI: 10.1038/s41419-023-05679-2.
    [17]
    WANG L, ZHANG X, LIU J, et al. Kinesin family member 15 can promote the proliferation of glioblastoma[J]. Math Biosci Eng, 2022, 19( 8): 8259- 8272. DOI: 10.3934/mbe.2022384.
    [18]
    MI J, MA S, CHEN W, et al. Integrative pan-cancer analysis of KIF15 reveals its diagnosis and prognosis value in nasopharyngeal carcinoma[J]. Front Oncol, 2022, 12: 772816. DOI: 10.3389/fonc.2022.772816.
    [19]
    GAO L, ZHANG W, ZHANG J, et al. KIF15-mediated stabilization of AR and AR-V7 contributes to enzalutamide resistance in prostate cancer[J]. Cancer Res, 2021, 81( 4): 1026- 1039. DOI: 10.1158/0008-5472.CAN-20-1965.
    [20]
    CHAN YT, LIN RJ, WANG YH, et al. The interplay between IGF-1R signaling and Hippo-YAP in breast cancer stem cells[J]. Cell Commun Signal, 2023, 21( 1): 81. DOI: 10.1186/s12964-023-01088-2.
    [21]
    TIAN LY, SMIT DJ, JÜCKER M. The role of PI3K/AKT/mTOR signaling in hepatocellular carcinoma metabolism[J]. Int J Mol Sci, 2023, 24( 3): 2652. DOI: 10.3390/ijms24032652.
    [22]
    LIU M, HUANG XD, HAN Z, et al. Effect of cadherin-17 on proliferation and apoptosis of colorectal cancer cells and its PI3K/AKT/m TOR signaling pathway regulatory mechanism[J]. J Jilin Univ(Med Edit), 2023, 49( 4): 1008- 1017. DOI: 10.13481/j.1671-587X.20230423.

    刘蒙, 黄晓东, 韩峥, 等. 钙黏蛋白17对结直肠癌细胞增殖和凋亡的影响及其PI3K/AKT/mTOR信号通路调节机制[J]. 吉林大学学报(医学版), 2023, 49( 4): 1008- 1017. DOI: 10.13481/j.1671-587X.20230423.
    [23]
    JIANG Q, GUAN Y, ZHENG J, et al. TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway[J]. Immun Inflamm Dis, 2023, 11( 3): e796. DOI: 10.1002/iid3.796.
    [24]
    LI Y, WANG S, JIN K, et al. UHMK1 promotes lung adenocarcinoma oncogenesis by regulating the PI3K/AKT/mTOR signaling pathway[J]. Thorac Cancer, 2023, 14( 12): 1077- 1088. DOI: 10.1111/1759-7714.14850.
    [25]
    CHEN J, LIU F, WU J, et al. Effect of STK3 on proliferation and apoptosis of pancreatic cancer cells via PI3K/AKT/mTOR pathway[J]. Cell Signal, 2023, 106: 110642. DOI: 10.1016/j.cellsig.2023.110642.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (300) PDF downloads(48) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return